Expects to deliver three Investigational New Drug (IND) applications in next three years based on next-generation ADC technology -- Two new ...
Recent Highlights In November 2024, Elicio presented a poster, “AMPLIFY-7P Phase 1a: Lymph node-targeted amphiphile therapeutic cancer vaccine in patients ... OS data in an oral presentation at the ...
Pro forma cash and investment balance of $683.9 million as of September 30, 2024 expected to provide runway through 2027 across a number of impactful portfolio milestones. WATER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback